Merchant K M, Gibb J W, Hanson G R
Department of Pharmacology and Toxicology, University of Utah, Salt Lake City 84112.
Eur J Pharmacol. 1989 Feb 7;160(3):409-12. doi: 10.1016/0014-2999(89)90098-8.
Activation of dopamine D-1 receptors with multiple administrations of SKF 38393 significantly increased the level of neurotensin-like immunoreactivity in the striatum and the nucleus accumbens. However, a similar treatment with the D-2 receptor-selective agonist, LY 171555, decreased the same in both structures; when the two drugs were administered concurrently, their individual effects were blocked. These results suggest that dopamine D-1 and D-2 receptors antagonistically regulate neurotensin systems of the striatum and nucleus accumbens. On the other hand, blockade of D-2 receptors (with sulpiride) elevated, while D-1 receptors blockade (with SCH 23390) caused no change in the level of neurotensin in both these structures. Dopamine D-1 receptors did not appear to contribute to the sulpiride-mediated effect as concurrent administration of SCH 23390 did not alter the response.
多次给予SKF 38393激活多巴胺D-1受体可显著提高纹状体和伏隔核中神经降压素样免疫反应水平。然而,用D-2受体选择性激动剂LY 171555进行类似处理会降低这两个结构中的神经降压素样免疫反应水平;当同时给予这两种药物时,它们各自的作用会被阻断。这些结果表明,多巴胺D-1和D-2受体对纹状体和伏隔核的神经降压素系统具有拮抗调节作用。另一方面,阻断D-2受体(用舒必利)可提高神经降压素水平,而阻断D-!受体(用SCH 23390)对这两个结构中的神经降压素水平没有影响。多巴胺D-1受体似乎对舒必利介导的作用没有贡献,因为同时给予SCH 23390不会改变反应。